Detection of microRNA Expression in Human Peripheral Blood Microvesicles

By M. Hunter, Noura Ismail, Xiaoli Zhang, B. Aguda, E. J. Lee, Lianbo Yu, Tao Xiao, Jeffrey M. Schafer, M. Lee, Thomas D. Schmittgen and 3 more. PLoS ONE, 2008

1,470 citations recorded by the source corpus.

Background MicroRNAs (miRNA) are small non-coding RNAs that regulate translation of mRNA and protein. Loss or enhanced expression of miRNAs is associated with several diseases, including cancer. However, the identification of circulating miRNA in healthy donors is not well characterized. Microvesicles, also known as exosomes or microparticles, circulate in the peripheral blood and can stimulate cellular signaling. In this study, we hypothesized that under normal healthy conditions, microvesicles contain miRNAs, contributing to biological homeostasis. Methodology/Principal Findings Microvesicles were isolated from the plasma of normal healthy individuals. RNA was isolated from both the microvesicles and matched mononuclear cells and profiled for 420 known mature miRNAs by real-time PCR. Hierarchical clustering of the data sets indicated significant differences in miRNA expression between peripheral blood mononuclear cells (PBMC) and plasma microvesicles. We observed 71 miRNAs co-expressed between microvesicles and PBMC. Notably, we found 33 and 4 significantly differentially expressed miRNAs in the plasma microvesicles and mononuclear cells, respectively. Prediction of the gene targets and associated biological pathways regulated by the detected miRNAs was performed. The majority of the miRNAs expressed in the microvesicles from the blood were predicted to regulate cellular differentiation of blood cells and metabolic pathways. Interestingly, a select few miRNAs were also predicted to be important modulators of immune function. Conclusions This study is the first to identify and define miRNA expression in circulating plasma microvesicles of normal subjects. The data generated from this study provides a basis for future studies to determine the predictive role of peripheral blood miRNA signatures in human disease and will enable the definition of the biological processes regulated by these miRNA.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/0cdf6a7c832c13fbd0b00d0d405f9e1d6a1d1a3d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

Citations in the corpus

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. (2010, background): “, 2009; Taylor and Gercel-Taylor, 2008), peripheral blood cells (Hunter et al., 2008; Valadi et al., 2007), endothelial progenitor cells (Deregibus et al.”
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma (2011, background): “Vesicles proposed as carriers of circulating miRNAs include exosomes, which are 50- to 90-nm vesicles arising from multivesicular bodies and released by exocytosis (11), as well as larger membrane-bound particles including microvesicles that range in size to as large as 1 μm (12, 13).”
MicroRNAs: the fine-tuners of Toll-like receptor signalling (2011, background): “For example, miRNAs have been shown to be contained in exosomes”
Exosomes and other extracellular vesicles in host–pathogen interactions (2014, neutral): “The source of these exosomes/extracellular vesicles were cultured cells [60] and body fluids [61,62].”
Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. (2012, methodology): “Delivery of exosome-shuttle miRNAs into the cytosol of DCs requires the following conditions: (1) endocytosis of exosomes followed by their back-fusion with the phagosome membrane and/or (2) fusion of the exogenous exosomes with the cell surface membrane.”
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function (2015, background): “The deﬁnition for such extracellular vesicles named as microvesicles, exosomes, and microparticles remains confusing among different reports [28–30].”
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. (2014, neutral): “These fibroblast-derived mediators may act in an autocrine or paracrine fashion between fibroblasts and cardiomyocytes to stimulate cardiac remodeling (5, 6).”
Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. (2016, background): “Indeed, inclusion of miRNAs in microvesicles, exosomes, apoptotic bodies, and complexes with proteins converts protection from RNase-dependent degradation (116, 244, 268).”
Extracellular vesicles: Exosomes, microvesicles, and friends (2013, background): “Later studies reported on the RNA contents of EV isolates from other cell cultures (Skog et al., 2008) and from body fluids (Hunter et al., 2008; Rabinowits et al., 2009; Michael et al., 2010).”